| Secondary |
| Drug Use For Unknown Indication |
40.6% |
| Cellulitis |
7.8% |
| Pain |
7.8% |
| Rheumatoid Arthritis |
7.8% |
| Depression |
4.7% |
| Heart Rate |
4.7% |
| Hyperlipidaemia |
4.7% |
| Hypertension |
4.7% |
| Hypothyroidism |
4.7% |
| Sleep Disorder |
4.7% |
| Umbilical Hernia Repair |
4.7% |
| Product Used For Unknown Indication |
3.1% |
|
| Enterovesical Fistula |
17.2% |
| Tendonitis |
17.2% |
| Somnolence |
13.8% |
| Vomiting |
13.8% |
| Hypotension |
10.3% |
| Overdose |
10.3% |
| Multiple Drug Overdose Intentional |
6.9% |
| Urine Output Decreased |
6.9% |
| Tendon Pain |
3.4% |
|
| Concomitant |
| Rheumatoid Arthritis |
41.5% |
| Drug Use For Unknown Indication |
9.2% |
| Hypertension |
7.4% |
| Product Used For Unknown Indication |
7.4% |
| Ankylosing Spondylitis |
3.9% |
| Pain |
3.7% |
| Back Pain |
3.5% |
| Peripheral Vascular Disorder |
3.5% |
| Arthritis |
3.1% |
| Diabetes Mellitus |
2.5% |
| Prophylaxis |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Depression |
1.8% |
| Cardiovascular Disorder |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
| Helicobacter Infection |
1.2% |
| Osteoporosis |
1.2% |
| Sciatica |
1.2% |
| Sleep Disorder |
1.2% |
| Analgesia |
1.0% |
|
| Peritoneal Tuberculosis |
11.6% |
| Vomiting |
9.8% |
| Basal Cell Carcinoma |
7.1% |
| Malaise |
7.1% |
| Urinary Tract Infection |
7.1% |
| Death |
6.3% |
| Lung Neoplasm Malignant |
5.4% |
| Faecal Incontinence |
4.5% |
| Serotonin Syndrome |
4.5% |
| Wound Infection |
4.5% |
| Osteomyelitis |
3.6% |
| Pulmonary Fibrosis |
3.6% |
| Renal Failure |
3.6% |
| Respiratory Failure |
3.6% |
| Tuberculosis |
3.6% |
| Weight Decreased |
3.6% |
| Cerebrovascular Accident |
2.7% |
| Myocardial Ischaemia |
2.7% |
| Oesophageal Cancer Metastatic |
2.7% |
| Oesophageal Carcinoma |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
46.2% |
| Asthma |
7.7% |
| Atrial Fibrillation |
7.7% |
| Cardiac Failure Congestive |
7.7% |
| Depression |
7.7% |
| Hyperthyroidism |
7.7% |
| Mania |
7.7% |
| Oral Candidiasis |
7.7% |
|
| International Normalised Ratio Increased |
100.0% |
|
